Why Cortexyme Shares Are Falling
Cortexyme Inc (NASDAQ: CRTX) shares are trading lower after the company's Phase 2/3 GAIN trial did not meet its co-primary endpoints.
Mid-Day Market Update: Dow Falls Over 100 Points; Silicon Laboratories Shares Spike Higher
Midway through trading Wednesday, the Dow traded down 0.30% to 35,648.39 while the NASDAQ rose 0.32% to 15,283.97. The S&P also fell, dropping 0.03% to 4,573.51.
44 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI) shares climbed 105.3% to $4.4350. AgriFORCE Growing Systems reported binding LOI to acquire a European agriculture/horticulture and agtech consulting firm for $29 million.
10 Biggest Price Target Changes For Wednesday
Raymond James raised Alphabet Inc. (NASDAQ: GOOGL) price target from $3,200 to $3,400. Alphabet shares fell 0.7% to $2,767.04 in pre-market trading.
B of A Securities Downgrades Cortexyme to Underperform
B of A Securities analyst Tazeen Ahmad downgrades Cortexyme (NASDAQ:CRTX) from Neutral to Underperform.
HC Wainwright & Co. Maintains Buy on Cortexyme, Lowers Price Target to $30
HC Wainwright & Co. analyst Andrew Fein maintains Cortexyme (NASDAQ:CRTX) with a Buy and lowers the price target from $200 to $30.
Why Cortexyme Shares Are Plunging 70% After Hours
Shares of a clinical-stage biopharmaceutical company are falling in after-hours trading Tuesday after the company shared an update.